Highlights
Cannabinoid receptor activation leads to massive mobilization of myeloid-derived suppressor cells with potent immunosuppressive properties
Article first published online: 25 NOV 2010
DOI: 10.1002/eji.201040667
Copyright © 2010 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Additional Information
How to Cite
Hegde, V. L., Nagarkatti, M. and Nagarkatti, P. S. (2010), Cannabinoid receptor activation leads to massive mobilization of myeloid-derived suppressor cells with potent immunosuppressive properties. Eur. J. Immunol., 40: 3358–3371. doi: 10.1002/eji.201040667
Publication History
- Issue published online: 25 NOV 2010
- Article first published online: 25 NOV 2010
- Manuscript Accepted: 15 SEP 2010
- Manuscript Revised: 12 AUG 2010
- Manuscript Received: 16 MAY 2010
Funded by
- National Institutes of Health, USA. Grant Numbers: R01-DA016545, R01-ES09098, R01-AI053703, R01-AI058300, R01-HL058641, P01-AT003961
Keywords:
- Arginase;
- Cannabinoid receptors;
- Granulocyte CSF;
- Immune suppression;
- Myeloid-derived suppressor cells
Abstract
Cannabinoid receptor activation by agents such as Δ9-tetrahydrocannabinol (THC) is known to trigger immune suppression. Here, we show that administration of THC in mice leads to rapid and massive expansion of CD11b+Gr-1+ myeloid-derived suppressor cells (MDSC) expressing functional arginase and exhibiting potent immunosuppressive properties both in vitro and in vivo. The induction of MDSC by THC was associated with a significant increase in granulocyte CSF. Moreover, administration of anti-granulocyte CSF Ab inhibited the induction of MDSC by THC. THC was able to induce MDSC in TLR4 mutant C3H and C57BL10/ScN mice and hence acted independently of TLR4. Accumulation of MDSC in the periphery with a corresponding decrease in the proportion of CD11b+Gr-1+ cells in the bone marrow, as well as in vivo BrdU labeling and cell-cycle analysis, showed that THC induced mobilization of these cells from bone marrow and their expansion in the periphery. Use of selective antagonists SR141716A and SR144528 against cannabinoid receptors 1 and 2, respectively, as well as receptor-deficient mice showed that induction of MDSC was mediated through activation of both cannabinoid receptors 1 and 2. These studies demonstrate that cannabinoid receptor signaling may play a crucial role in immune regulation via the induction of MDSC.

1521-4141/asset/2040_left.gif?v=1&s=92837c2f17424f89abf3f45e2642c107d62e6c04)
1521-4141/asset/EJI_right.gif?v=1&s=bce6d64154702bbe279104b1163baee31019fb77)
